| Gene symbol | MAGEA4 | Synonyms | CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B | Type of gene | protein-coding | |
| Chromosome | X | Map location | Xq28 | dbXrefs | Entrez:4103 MIM:300175 HGNC:HGNC:6802 Ensembl:ENSG00000147381 AllianceGenome:HGNC:6802 | |
| Description | MAGE family member A4 | |||||
| GTO ID | GTC1124 |
| Trial ID | JPRN-UMIN000010729 |
| Disease | Esophageal Cancer |
| Altered gene | MAGE-A4 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | MAGE-A4 TCR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Adoptive transfer of lymphocytes transduced with MAGE-A4-specific TCR gene following lymphodepleting conditioning for therapy-resistant esophageal cancer |
| Year | 2013 |
| Country | Japan |
| Company sponsor | Department of Immuno-gene Therapy, Mie University Graduate School of Medicine |
| Cohort1: dose level 1 | |||||||||
|
|||||||||
| Cohort2: dose level 2 | |||||||||
|
|||||||||